<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 10, 1997
MISONIX, INC.
- -------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
<TABLE>
<S> <C> <C>
New York 1-10986 11-2148932
- ---------------------------------------------------------------------------------------------
(State or other jurisdiction (Commission File Number) (IRS Employer Identification No.)
of incorporation)
</TABLE>
1938 New Highway, Farmingdale, New York 11735
- -------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (516) 694-9555
----------------------------
- -------------------------------------------------------------------------------
(Former name or former address, if changed since last report.)
Page 1 of 5 Pages Exhibit Index on Page 4
-----------------------
<PAGE>
Item 5. Other Events.
Warrants (the "Warrants") to purchase 729,128 shares of common stock,
par value $.01 per share ("Common Stock"), of MISONIX, INC. (the "Company"),
issued pursuant to a Warrant Agreement, dated as of January 23, 1992, between
the Company and Continental Stock Transfer and Trust Company (the "Warrant
Agreement"), were exercised as of the close of business on February 3, 1997.
The balance of Warrants issued pursuant to the Warrant Agreement concurrently
expired. Each Warrant was exercisable for one share of Common Stock at a
purchase price of $7.80 per share. As a result of such exercise, the Company
received gross proceeds of $5,687,198, which has been added to its working
capital, giving it approximately $9,326,864 in cash and marketable securities
as of this date. A total of 729,128 shares of fully registered Common Stock
were issued as a result of the foregoing exercise, increasing the number of
issued and outstanding shares of the Company to 3,559,128 as of this date.
Attached as Exhibit 1 hereto, is a copy of a release issued by the
Company announcing the exercise of the Warrants.
Item 7. Financial Statements and Exhibits.
(1) Exhibits.
(A) Press Release, dated February 10, 1997.
Page 2 of 5 Pages
- 2 -
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
MISONIX, INC.
Date: February 11, 1997 By: /s/Joseph Librizzi
-------------------------------------
Joseph Librizzi
President and Chief Executive Officer
Page 3 of 5 Pages
- 3 -
<PAGE>
EXHIBIT INDEX
(1) Press Release, dated February 10, 1997
Page 4 of 5 Pages
- 4 -
<PAGE>
Exhibit 1 to Form 8-K
FOR: MISONIX, INC.
1938 New Highway
Farmingdale, NY 11735
FOR IMMEDIATE RELEASE
---------------------
MISONIX ANNOUNCES EXERCISE OF
729,128 PUBLIC WARRANTS
FARMINGDALE, NEW YORK, FEBRUARY 11, 1997..... Misonix Inc. (NASDAQ:
MSON) today announced the exercise of 729,128 of the publicly issued Redeemable
Warrants as of the close of business on February 3, 1997, the issuance of a
like number of common shares as a result, and the expiration of the balance of
these warrants. As a result, the Company received gross proceeds of $5,687,198,
which has been added to its working capital, giving it approximately $9,326,864
in cash and marketable securities as of this date.
Misonix, Inc. develops, manufactures and markets medical, scientific
and industrial ultrasonic and air pollution control systems.
Contact: Peter Gerstheimer
Vice President and Chief Financial Officer
Misonix, Inc.
(516) 694-9555
- 5 -
